Apimeds Pharmaceuticals Us, INC. (APUS) SEC Filings — 2025

Filings

• Apimeds Pharmaceuticals Files 8-K/A Amendment — 8-K/A · Dec 10, 2025
• Apimeds Pharmaceuticals Files 8-K with Multiple Material Events — 8-K · Dec 2, 2025
• Apimeds Pharmaceuticals Us, INC. 8-K Filing — 8-K · Nov 18, 2025
• Apimeds' Losses Mount Amid R&D Surge, IPO Boosts Cash to $7M — 10-Q · Nov 12, 2025
• Apimeds Pharmaceuticals Files 8-K for Bylaws and Financials — 8-K · Oct 16, 2025
• Apimeds Pharmaceuticals Files Q2 2025 10-Q — 10-Q · Aug 19, 2025
• Apimeds Pharmaceuticals Files 8-K — 8-K · Jul 16, 2025
• Apimeds Pharmaceuticals Reports Officer and Director Changes — 8-K · Jun 5, 2025
• Apimeds Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 20, 2025
• Apimeds Pharmaceuticals Files 8-K on Agreements and Equity Sales — 8-K · May 12, 2025
• Apimeds Pharmaceuticals Files 10-K Amendment — 10-K/A · May 2, 2025
• Apimeds Pharmaceuticals Files 2024 10-K Report — 10-K · Apr 15, 2025
• Apimeds Pharmaceuticals Files S-1/A Amendment — S-1/A · Feb 10, 2025
• Apimeds Pharmaceuticals Files S-1/A Amendment — S-1/A · Feb 6, 2025
• Apimeds Pharmaceuticals Files S-1/A Amendment — S-1/A · Jan 29, 2025
• Apimeds Pharmaceuticals Files S-1/A Amendment — S-1/A · Jan 10, 2025